{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:58:02Z","timestamp":1776848282648,"version":"3.51.2"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>High-dose methotrexate (HDMTX) remains integral to acute lymphoblastic leukemia\/lymphoma (ALL) treatment. However, high MTX concentrations can lead to acute kidney injury (KI) and other toxicities. We investigated whether measured GFR (mGFR) by iohexol clearance better predicts delayed MTX excretion and\/or toxicity compared with standard of care using an estimated GFR (eGFR). We also examined if KI biomarkers (urine KIM-1 and clusterin, serum cystatin C, and plasma FGF23) identify KI more frequently than serum creatinine (sCr) alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Procedure:<\/jats:title>\n                    <jats:p>ALL patients receive 4 doses of HDMTX with alkalinized IV fluids, leucovorin rescue, and MTX clearance per the standard of care. We obtained mGFRs before HDMTX doses 1 and 4. eGFR was calculated using the Schwartz formula and biomarkers of KI were collected around each HDMTX dose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Overall, there were some associations between the mGFR\/biomarkers with KI and other toxicities, but mGFR was not found to be a better predictor of delayed MTX clearance or toxicity than eGFR. The biomarkers did not predict KI development more frequently than sCr alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>On the basis of this study, there is no evidence that the current standard of care for determining the GFR in advance of HDMTX administration, nor postadministration management, should be adjusted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mph.0000000000003075","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T16:00:17Z","timestamp":1750694417000},"page":"e235-e240","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Iohexol Clearance and Biomarker Analysis to Predict Toxicity in Patients With Acute Lymphoblastic Leukemia and Lymphoma Receiving High-dose Methotrexate"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6235-315X","authenticated-orcid":false,"given":"Amy L.","family":"Walz","sequence":"first","affiliation":[{"name":"Division of Hematology, Oncology, Neuro-Oncology, Department of Pediatrics, and Stem Cell Transplant, Ann and Robert H. Lurie Children\u2019s Hospital of Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masha","family":"Kocherginsky","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Preventive Medicine, Northwestern University, Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Newmark","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, Neuro-Oncology, Department of Pediatrics, and Stem Cell Transplant, Ann and Robert H. Lurie Children\u2019s Hospital of Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Brooks","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics, Northwestern University Feinberg School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Walterhouse","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology, Neuro-Oncology, Department of Pediatrics, and Stem Cell Transplant, Ann and Robert H. Lurie Children\u2019s Hospital of Chicago"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00614310","article-title":"Renal excretion and pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following a 24-h high dose infusion of methotrexate in children","volume":"30","author":"Winograd","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"R2-20260422","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/j.ajkd.2010.07.013","article-title":"Comparison of plasma clearance of iohexol and urinary clearance of inulin for measurement of GFR in children","volume":"57","author":"Berg","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00280-002-0552-1","article-title":"High-dose methotrexate: on the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lymphoblastic leukaemia (ALL)","volume":"51","author":"Sk\u00e4rby","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/00365518809167491","article-title":"Contrast media as markers for glomerular filtration: a pharmacokinetic comparison of four agents","volume":"48","author":"B\u00e4ck","year":"1988","journal-title":"Scand J Clin Lab Invest"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/00365519009091579","article-title":"Determination of glomerular filtration rate using iohexol clearance and capillary sampling","volume":"50","author":"Krutz\u00e9n","year":"1990","journal-title":"Scand J Clin Lab Invest"},{"key":"R7-20260422","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1681\/ASN.V62257","article-title":"Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate","volume":"6","author":"Gaspari","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3109\/00365519109104587","article-title":"The clearance of iohexol as a measure of the glomerular filtration rate in children with chronic renal failure","volume":"51","author":"Stake","year":"1991","journal-title":"Scand J Clin Lab Invest"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00467-003-1086-4","article-title":"Metabolic status in diabetes mellitus affects markers for glomerular filtration rate","volume":"18","author":"Holmquist","year":"2003","journal-title":"Pediatr Nephrol"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00467-007-0470-x","article-title":"Biomarkers for the early detection of acute kidney injury","volume":"23","author":"Nguyen","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R11-20260422","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1523-1755.2004.00861.x","article-title":"Early detection of acute renal failure by serum cystatin C","volume":"66","author":"Herget-Rosenthal","year":"2004","journal-title":"Kidney Int"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ki.2013.150","article-title":"Plasma FGF23 levels increase rapidly after acute kidney injury","volume":"84","author":"Christov","year":"2013","journal-title":"Kidney Int"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2215\/CJN.00550112","article-title":"FGF-23 levels in patients with AKI and risk of adverse outcomes","volume":"7","author":"Leaf","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R14-20260422","first-page":"246","article-title":"Acute Kidney Injury (AKI) biomarker","volume":"44","author":"Adiyanti","year":"2012","journal-title":"Acta Med Indones"},{"key":"R15-20260422","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1523-1755.2002.00433.x","article-title":"Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury","volume":"62","author":"Han","year":"2002","journal-title":"Kidney Int"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.toxlet.2013.08.003","article-title":"Renal biomarkers predict nephrotoxicity after paraquat","volume":"222","author":"Wunnapuk","year":"2013","journal-title":"Toxicol Lett"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nbt.1622","article-title":"Urinary clusterin, cystatin C, beta2-microglobulin and total protein as markers to detect drug-induced kidney injury","volume":"28","author":"Dieterle","year":"2010","journal-title":"Nat Biotechnol"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00467-006-0358-1","article-title":"Glomerular filtration rate measurement and estimation in chronic kidney disease","volume":"22","author":"Schwartz","year":"2007","journal-title":"Pediatr Nephrol"},{"key":"R19-20260422","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/sj.ki.5000385","article-title":"Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children","volume":"69","author":"Schwartz","year":"2006","journal-title":"Kidney Int"},{"key":"R20-20260422","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1152\/ajplegacy.1955.181.2.330","article-title":"Volumes of distribution and clearances of intravenously injected creatinine in the dog","volume":"181","author":"Sapirstein","year":"1955","journal-title":"Am J Physiol"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","article-title":"Preventing and managing toxicities of high-dose methotrexate","volume":"21","author":"Howard","year":"2016","journal-title":"Oncologist"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:01:01Z","timestamp":1776844861000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003075","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"2024-11-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-15","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}